Boryeong Prucalopride Tablets 2 mg (Prucalopride Succinate)
Prucalopride Succinate 2.642mg
Tablet · Prescription medication
Boryeong Co., Ltd.
MFDS item code 201902345 · Approved 2019.04.16
This product's status changed to Expired on 2024.04.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of chronic constipation symptoms
This medication is used to treat the constipation symptoms of adult patients with chronic constipation when the use of laxatives has been ineffective in relieving symptoms. It can provide effective relief for those suffering from chronic constipation and helps to facilitate bowel movements.
This medication is administered orally and can be taken at any time of the day, with or without meals. The recommended adult dosage is 2 mg once daily. For elderly patients aged 65 and over, the initial dose is 1 mg once daily, which may be increased to 2 mg once daily if necessary. For patients with severe renal impairment and severe hepatic impairment, the dosage is 1 mg once daily.
This medication should not be used in certain patients. Those with allergies to the active ingredients or excipients should avoid taking it. It should not be used by patients with severely impaired kidney function requiring dialysis. Patients with structural or functional problems in the intestine, such as perforation, obstruction, Crohn's disease, or severe inflammatory diseases like ulcerative colitis should also refrain from taking it. This medication contains lactose and should not be taken by patients with genetic disorders that prevent lactose digestion. Patients with severe renal impairment should use this medication cautiously with a reduced dosage. Its safety has not been sufficiently confirmed in patients with serious diseases affecting the liver, heart, lungs, or nervous system; therefore, caution is necessary. Special attention should be paid to patients with a history of arrhythmias or ischemic heart disease. Patients with significantly impaired liver function should also use it at a reduced dosage. Care should be taken when this medication is taken alongside other drugs that can alter the electrical properties of heartbeats. During treatment, gastrointestinal symptoms such as headaches, abdominal pain, nausea, and diarrhea may frequently occur, though most are mild and improve over time. Fatigue or dizziness may also be experienced, and if symptoms are severe, consult a physician. If new heart palpitations occur, notify healthcare providers immediately. The use of this medication is not recommended during pregnancy, and women of childbearing age should use effective contraception while taking it. Nursing mothers are advised to avoid this medication. The use of this medication is not recommended for children or adolescents under 18 years of age. In case of overdose, symptoms such as headache, nausea, and diarrhea may occur, requiring appropriate treatment based on the symptoms. This medication can cause dizziness or fatigue at the beginning of treatment, so caution is advised when driving or operating machinery. Store this medication out of reach of children and in its original container to avoid moisture.
Chest discomfort, ventricular premature contractions
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that is resistant to light and air, avoiding humid areas, at a cool room temperature of 1 to 30 degrees Celsius.
Pink round film-coated tablet
28 tablets (7 tablets/PTPX4)/box
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Prucalopride Succinate 2.642mg
Tablet · Prescription medication
Boryeong Co., Ltd.

Prucalopride Succinate 1.321mg
Tablet · Prescription medication
Hanmi Menarini Co., Ltd.

Prucalopride Succinate 2.642mg
Tablet · Prescription medication
Korea Menarini Co., Ltd.
Prucalopride Succinate 1.321mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Prucalopride Succinate 2.642mg
Tablet · Prescription medication
Genewell Science Co., Ltd.

Prucalopride Succinate 2.642mg
Tablet · Prescription medication
Yooyoung Pharmaceutical Co., Ltd.

Prucalopride Succinate 1.321mg
Tablet · Prescription medication
YuYoung Pharmaceutical Co., Ltd.
Prucalopride Succinate 1.321mg
Tablet · Prescription medication
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.